Clinical Trial Update: Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects [Phase 2]

View source ↗

Summary

The update states that the Phase 2 multiple-dose study of BMS-646256 in obese subjects has been terminated; the trial was to assess efficacy, safety and pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BMS-646256

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obesity | Phase 2 | Status: TERMINATED